Advanced search
Publication Cover
Expert Opinion on Emerging Drugs Volume 27, 2022 - Issue 2
Submit an article Journal homepage
337
Views
3
CrossRef citations to date
0
Altmetric
Review

Assessing the developing pharmacotherapeutic landscape in hepatitis B treatment: a spotlight on drugs in phase II clinical trials

Rex Wan-Hin Huia Department of Medicine, The University of Hong Kong, Hong KongORCID Iconhttps://orcid.org/0000-0001-7447-7539View further author information
ORCID Icon,
Lung Yi Maka Department of Medicine, The University of Hong Kong, Hong Kong;b State Key Laboratory of Liver Research, The University of Hong Kong, Hong KongView further author information
,
Wai-Kay Setoa Department of Medicine, The University of Hong Kong, Hong Kong;b State Key Laboratory of Liver Research, The University of Hong Kong, Hong KongCorrespondence[email protected]
View further author information
&
Man-Fung Yuena Department of Medicine, The University of Hong Kong, Hong Kong;b State Key Laboratory of Liver Research, The University of Hong Kong, Hong KongCorrespondence[email protected]
View further author information
Pages 127-140 | Received 25 Feb 2022, Accepted 04 May 2022, Published online: 15 May 2022

Citations (3)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Rex Wan-Hin Hui, Lung-Yi Mak, Wai-Kay Seto, Man-Fung Yuen & James Fung. (2023) Chronic hepatitis B: a scoping review on the guidelines for stopping nucleos(t)ide analogue therapy. Expert Review of Gastroenterology & Hepatology 17:5, pages 443-450.
Read now

Articles from other publishers (2)

Huihui Yang, Weiwei Yao & Jinfei Yang. (2023) Overview of the development of HBV small molecule inhibitors. European Journal of Medicinal Chemistry 249, pages 115128.
Crossref
Rex Wan-Hin Hui, Lung-Yi Mak, Ka-Shing Cheung, James Fung, Wai-Kay Seto & Man-Fung Yuen. (2022) Novel Combination Strategies With Investigational Agents for Functional Cure of Chronic Hepatitis B Infection. Current Hepatology Reports 21:4, pages 59-67.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.